Modern Arc Radiotherapy Keeps More Saliva Flowing After Head and Neck Cancer Treatment
A clinical study finds that patients treated with VMAT had roughly double the salivary flow and oral moisture of those ...
A clinical study finds that patients treated with VMAT had roughly double the salivary flow and oral moisture of those ...
Three-year follow-up of the phase 3 KEYNOTE-966 trial confirms that adding pembrolizumab to gemcitabine and cisplatin chemotherapy maintains a durable ...
A Japanese retrospective study of 244 thoracic cancer patients finds that baseline hypertension triples the risk of cisplatin-induced kidney injury ...
The Phase II portion of the NRG-HN009 trial found that weekly cisplatin did not significantly reduce acute toxicity compared with ...
A Japanese case report details how salvage chemotherapy for a brain germinoma relapse twelve years after childhood treatment triggered severe, ...
A new study shows that changing how diphosphine ligands coordinate to cyclometalated platinum(II) complexes switches their DNA-binding mode from attempted ...
A new NCCN survey finds that every responding US cancer center is facing at least one cancer drug shortage, with ...
New research shows that BH3 mimetic drugs targeting antiapoptotic Bcl-2 family proteins can sensitize bladder cancer cells and patient-derived tumor ...
New research reveals that the RNA splicing factor LUC7L2 drives ferroptotic kidney damage from cisplatin by corrupting the splicing of ...
Cryo-electron microscopy captures RNA polymerase II remodeling cisplatin-induced DNA interstrand crosslinks into a novel conformation that blocks the active site, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine